Marc Vangerven

Healthcare Investor at Summit Partners

📍 United Kingdom🔄 Updated September 2026💼 2 investments📅 1 years investing🗓 Last invested Aug 2025
VC🌍 United Kingdom
2
Total investments
0
Early stage
0
Mid stage
0
Late stage
1y
Years active

Portfolio

0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 3 entries
All (3)
Investments (2)
Board (1)
2025
Investor
Aug 2025
IgniteData’s Archer technology is transforming the way hospitals and research sites transfer data for clinical trials. EHR-to-EDC data transfer provides fast, accurate patient data for clinical studies, significantly reducing the requirement for laborious data transcription and source data verification (SDV).
Investor & Board Observer
Jun 2025
Industry leaders in patient sample management and traceability. Improving patient safety and AP lab workflow by advancing sample chain-of-custody. #patientsafety The Dreampath portfolio is built upon: -The importance patient safety and advancing it through proper chain-of-custody for patient samples in the anatomic pathology (AP) lab -The need for robust, reliable, and accurate access to samples in the AP lab (both clinical and research environments) -Fina, Crystal and Hydra track and monitor patient samples in the laboratory workflow, from receipt to diagnosis www.dreampathdx.net YouTube: @DreampathDiagnostics Twitter: @DreampathDx
2022
Investment Professional | Healthcare
Sep 2022
Summit Partners is a global alternative investment firm with capital dedicated to growth equity, fixed income, and public equity opportunities. The Summit Partners’ strategy is grounded in a foundational belief that profitable growth is the most reliable path to building a durable business and creating long-term value. For four decades, the Summit team has focused on partnering with and powering the growth of great people and great companies. Summit invests across growth sectors of the economy and has invested in more than 550 companies in technology, healthcare, and other growth industries including financial services, consumer, business services and industrial technology. These companies have completed more than 175 public equity offerings, and more than 250 have been acquired through strategic mergers and sales. Summit maintains offices in North America and Europe and invests in companies around the world.